Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie J Calvert

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Nature Medicine|November 17, 2021
Patient-reported outcomes in the regulatory approval of medical devicesSamantha Cruz Rivera, Andrew P Dickens, Olalekan Lee Aiyegbusi, et al.
Ophthalmology|January 30, 2021
Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior SegmentMohammad O Tallouzi, Jonathan M Mathers, David J Moore, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 14, 2020
International guidance on the selection of patient-reported outcome measures in clinical trials: a reviewNorah L Crossnohere, Michael Brundage, Melanie J Calvert, et al.
BMJ Open Ophthalmology|July 30, 2020
Outcomes important to patients with non-infectious posterior segment-involving uveitis: a qualitative studyMohammad O Tallouzi, David J Moore, Nicholas Bucknall, et al.
Contemporary Clinical Trials|August 16, 2022
Implementation of patient-reported outcome measures in real-world evidence studies: Analysis of ClinicalTrials.gov records (1999-2021)Konrad Maruszczyk, Olalekan Lee Aiyegbusi, Victor Roth Cardoso, et al.
Nature Communications|December 9, 2020
Patient and public perspectives on cell and gene therapies: a systematic reviewOlalekan Lee Aiyegbusi, Karen Macpherson, Lauren Elston, et al.
Trials|January 7, 2021
Reporting guidelines for clinical trials of artificial intelligence interventions: the SPIRIT-AI and CONSORT-AI guidelinesHussein Ibrahim, Xiaoxuan Liu, Samantha Cruz Rivera, et al.
Multiple Sclerosis and Related Disorders|October 15, 2023
The effect of disease modifying therapies on fatigue in multiple sclerosisSamantha Cruz Rivera, Olalekan Lee Aiyegbusi, Daniela Piani Meier, et al.
The Cochrane Database of Systematic Reviews|December 19, 2018
Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitisRobert J Barry, Mohammad O Tallouzi, Nick Bucknall, et al.
Nature Medicine|March 5, 2021
The need for ethical guidance for the use of patient-reported outcomes in research and clinical practiceSamantha Cruz Rivera, Rebecca Mercieca-Bebber, Olalekan Lee Aiyegbusi, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Nature Medicine|November 17, 2021
Patient-reported outcomes in the regulatory approval of medical devicesSamantha Cruz Rivera, Andrew P Dickens, Olalekan Lee Aiyegbusi, et al.
Ophthalmology|January 30, 2021
Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior SegmentMohammad O Tallouzi, Jonathan M Mathers, David J Moore, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 14, 2020
International guidance on the selection of patient-reported outcome measures in clinical trials: a reviewNorah L Crossnohere, Michael Brundage, Melanie J Calvert, et al.
BMJ Open Ophthalmology|July 30, 2020
Outcomes important to patients with non-infectious posterior segment-involving uveitis: a qualitative studyMohammad O Tallouzi, David J Moore, Nicholas Bucknall, et al.
Contemporary Clinical Trials|August 16, 2022
Implementation of patient-reported outcome measures in real-world evidence studies: Analysis of ClinicalTrials.gov records (1999-2021)Konrad Maruszczyk, Olalekan Lee Aiyegbusi, Victor Roth Cardoso, et al.
Nature Communications|December 9, 2020
Patient and public perspectives on cell and gene therapies: a systematic reviewOlalekan Lee Aiyegbusi, Karen Macpherson, Lauren Elston, et al.
Trials|January 7, 2021
Reporting guidelines for clinical trials of artificial intelligence interventions: the SPIRIT-AI and CONSORT-AI guidelinesHussein Ibrahim, Xiaoxuan Liu, Samantha Cruz Rivera, et al.
Multiple Sclerosis and Related Disorders|October 15, 2023
The effect of disease modifying therapies on fatigue in multiple sclerosisSamantha Cruz Rivera, Olalekan Lee Aiyegbusi, Daniela Piani Meier, et al.
The Cochrane Database of Systematic Reviews|December 19, 2018
Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitisRobert J Barry, Mohammad O Tallouzi, Nick Bucknall, et al.
Nature Medicine|March 5, 2021
The need for ethical guidance for the use of patient-reported outcomes in research and clinical practiceSamantha Cruz Rivera, Rebecca Mercieca-Bebber, Olalekan Lee Aiyegbusi, et al.
Pageof 9